Lv1
20 积分 2024-11-17 加入
NQO1 alleviates renal fibrosis by inhibiting the TLR4/NF-κB and TGF-β/Smad signaling pathways in diabetic nephropathy
5天前
已完结
Molecular Mechanism of Finerenone in Treating Diabetic Nephropathy Based on Bioinformatics
6天前
已完结
Lupenone improves type 2 diabetic nephropathy by regulating NF-κB pathway-mediated inflammation and TGF-β1/Smad/CTGF-associated fibrosis
8天前
已完结
The non-steroidal mineralocorticoid receptor antagonist finerenone prevents cardiac fibrotic remodeling
1个月前
已完结
Ruboxistaurin attenuates diabetic nephropathy via modulation of TGF-β1/Smad and GRAP pathways
1个月前
已完结
Fenofibrate attenuates diabetic nephropathy in experimental diabetic rat's model via suppression of augmented TGF-β1/Smad3 signaling pathway
1个月前
已完结
Fenofibrate attenuates diabetic nephropathy in experimental diabetic rat's model via suppression of augmented TGF-β1/Smad3 signaling pathway
1个月前
已完结
Biomarkers of diabetic nephropathy: A 2017 update
3个月前
已完结
Mineralocorticoid receptor antagonists in diabetic kidney disease — mechanistic and therapeutic effects
3个月前
已完结
Cardiorenal protection with SGLT2 inhibitors in patients with diabetes mellitus: from biomarkers to clinical outcomes in heart failure and diabetic kidney disease
3个月前
已完结
皖公网安备34019202002308
